Patients with low-risk Myelodysplastic Syndrome (MDS) carrying the SF3B1 mutation are receiving increased attention. This mutation, common in patients, offers…
A new study explores the optimal combined atrial fibrillation treatment for individuals with myeloproliferative neoplasms (MPN). These blood cancers significantly…